Protective effects of calcium antagonists in different organs and tissues

P A van Zwieten1

  • 1Department of Pharmacotherapy, Academic Medical Centre, Amsterdam, The Netherlands.

American Heart Journal
|February 1, 1993
PubMed

Insights

Calcium antagonists offer organ protection in ischemic conditions. Clinical trials confirm their benefits for the heart, brain, blood vessels, and kidneys, validating earlier scientific claims.

Area of Science:

  • Pharmacology
  • Cardiology
  • Neurology
  • Nephrology

Background:

  • Calcium antagonists are known for vasodilator and antivasoconstrictor activities.
  • Basic science suggested direct anti-ischemic effects, but clinical value was uncertain.
  • Recent large clinical trials have confirmed organ-protective effects.

Purpose of the Study:

  • To review the evidence for the organ-protective activity of calcium antagonists.
  • To highlight clinical benefits in various tissues.

Main Methods:

  • Review of clinical trials and scientific evidence.
  • Analysis of data from studies on heart, brain, blood vessels, and kidneys.

Main Results:

  • Verapamil and diltiazem reduce reinfarction and mortality rates.
  • Nimodipine prevents neurologic deficits post-subarachnoid hemorrhage; flunarizine has antimigraine effects.
  • Israpidine and lacidipine show antiatherogenic potential; several agents protect kidneys from toxicity.

Conclusions:

  • Calcium antagonists demonstrate significant organ-protective effects in ischemic disorders.
  • Clinical evidence supports the use of specific calcium antagonists for treating various conditions.

Related Concept Videos

Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
Synthesis and Functions of Calcitonin00:51

Synthesis and Functions of Calcitonin

Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...